Paclitaxel 6 MG/ML Injectable Solution — RxCUI 312199
RxNorm drug concept · Semantic clinical drug
RxCUI 312199
Semantic clinical drug · SCD
● Current RxNorm concept 33 FDA products
38 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI312199
Official namePaclitaxel 6 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspaclitaxel 30 MG per 5 ML Injectable Solution; paclitaxel 100 MG per 16.7 ML Injectable Solution; paclitaxel 150 MG per 25 ML Injectable Solution; paclitaxel 300 MG per 50 ML Injectable Solution
FDA products mapped33
Package NDCs mapped38
Reported Medicaid activity (SDUD)44,452 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Paclitaxel (with polyoxyethylated castor oil) Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Paclitaxel works by jamming the internal machinery that cancer cells use to divide. Cells have a scaffolding made of tiny tubes (microtubules) that they build and tear down as they...
- What exactly does paclitaxel do — how does it fight cancer?
- Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) is given through an IV infusion at a clinic or hospital — it can't be taken at home. The infusion itsel...
- How will I receive this medicine, and how often will I need to come in?
🕸️ Concept Web — How Paclitaxel 6 MG/ML Injectable Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Paclitaxel 6 MG/ML Injectable Solution
RxCUI 312199 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Paclitaxel
56946IN
-
Paclitaxel
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Paclitaxel Injectable Solution
377111SCDF -
Paclitaxel Injectable Product
1163532SCDG -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
Paclitaxel Injectable Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Paclitaxel 6 MG/ML
316429SCDC
-
Paclitaxel 6 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Paclitaxel 6 MG/ML
SCDC · 316429 -
Paclitaxel Injectable Solution
SCDF · 377111 -
Paclitaxel Injectable Product
SCDG · 1163532
📦 FDA Products & Package NDCs
33 products · 38 package NDCs
38 package NDCs map to RxCUI 312199 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00703-3213-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3213-01) / 5 mL in 1 V... | Paclitaxel | Teva Parenteral Medicines, Inc. | 2020-07-07 |
| 00703-3213-81 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3213-81) / 5 mL in 1 V... | Paclitaxel | Teva Parenteral Medicines, Inc. | 2020-07-07 |
| 00703-3216-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3216-01) / 16.7 mL in... | Paclitaxel | Teva Parenteral Medicines, Inc. | 2020-03-25 |
| 00703-3216-81 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3216-81) / 16.7 mL in... | Paclitaxel | Teva Parenteral Medicines, Inc. | 2020-03-05 |
| 00703-3217-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3217-01) / 25 mL in 1... | Paclitaxel | Teva Parenteral Medicines, Inc. | 2020-03-05 |
| 00703-3218-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3218-01) / 50 mL in 1... | Paclitaxel | Teva Parenteral Medicines, Inc. | 2020-03-05 |
| 00703-3218-81 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3218-81) / 50 mL in 1... | Paclitaxel | Teva Parenteral Medicines, Inc. | 2020-03-05 |
| 16714-0137-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (16714-137-01) / 50 mL in 1... | Paclitaxel | Northstar Rx LLC | 2021-01-25 |
| 23155-0882-31 | 1 VIAL, MULTI-DOSE in 1 CARTON (23155-882-31) / 5 mL in 1 V... | PACLITAXEL PACLITAXEL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-08-31 |
| 23155-0883-31 | 1 VIAL, MULTI-DOSE in 1 CARTON (23155-883-31) / 16.7 mL in... | PACLITAXEL PACLITAXEL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-08-31 |
| 23155-0884-31 | 1 VIAL, MULTI-DOSE in 1 CARTON (23155-884-31) / 50 mL in 1... | PACLITAXEL PACLITAXEL | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2023-08-31 |
| 25021-0255-05 | 1 VIAL in 1 CARTON (25021-255-05) / 5 mL in 1 VIAL | Paclitaxel | Sagent Pharmaceuticals | 2024-02-01 |
| 25021-0255-17 | 1 VIAL in 1 CARTON (25021-255-17) / 16.7 mL in 1 VIAL | Paclitaxel | Sagent Pharmaceuticals | 2024-02-01 |
| 25021-0255-50 | 1 VIAL in 1 CARTON (25021-255-50) / 50 mL in 1 VIAL | Paclitaxel | Sagent Pharmaceuticals | 2024-02-01 |
| 46708-0620-05 | 1 VIAL, MULTI-DOSE in 1 CARTON (46708-620-05) / 5 mL in 1 V... | Paclitaxel | Alembic Pharmaceuticals Limited | 2022-10-20 |
| 46708-0621-17 | 1 VIAL, MULTI-DOSE in 1 CARTON (46708-621-17) / 16.7 mL in... | Paclitaxel | Alembic Pharmaceuticals Limited | 2022-10-20 |
| 46708-0622-50 | 1 VIAL, MULTI-DOSE in 1 CARTON (46708-622-50) / 50 mL in 1... | Paclitaxel | Alembic Pharmaceuticals Limited | 2022-10-20 |
| 61703-0015-04 | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-015-04) / 5 mL in 1 V... | Paclitaxel | Hospira, Inc. | 2025-04-08 |
| 61703-0342-09 | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-09) / 5 mL in 1 V... | Paclitaxel | Hospira, Inc. | 2004-03-01 |
| 61703-0342-22 | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-22) / 16.7 mL in... | Paclitaxel | Hospira, Inc. | 2004-03-01 |
| 61703-0342-50 | 1 VIAL, MULTI-DOSE in 1 CARTON (61703-342-50) / 50 mL in 1... | Paclitaxel | Hospira, Inc. | 2004-03-01 |
| 62332-0620-05 | 1 VIAL, MULTI-DOSE in 1 CARTON (62332-620-05) / 5 mL in 1 V... | Paclitaxel | Alembic Pharmaceuticals Inc. | 2022-10-20 |
| 62332-0621-17 | 1 VIAL, MULTI-DOSE in 1 CARTON (62332-621-17) / 16.7 mL in... | Paclitaxel | Alembic Pharmaceuticals Inc. | 2022-10-20 |
| 62332-0622-50 | 1 VIAL, MULTI-DOSE in 1 CARTON (62332-622-50) / 50 mL in 1... | Paclitaxel | Alembic Pharmaceuticals Inc. | 2022-10-20 |
| 63323-0763-16 | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-763-16) / 16.7 mL in... | Paclitaxel | Fresenius Kabi USA, LLC | 2009-03-20 |
| 63323-0763-50 | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-763-50) / 50 mL in 1... | Paclitaxel | Fresenius Kabi USA, LLC | 2009-03-20 |
| 68001-0516-27 | 1 VIAL, MULTI-DOSE in 1 CARTON (68001-516-27) / 50 mL in 1... | Paclitaxel | BluePoint Laboratories | 2021-09-14 |
| 68001-0705-27 | 1 VIAL, MULTI-DOSE in 1 CARTON (68001-705-27) / 50 mL in 1... | Paclitaxel | BluePoint Laboratories | 2026-04-09 |
| 68083-0178-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (68083-178-01) / 5 mL in 1 V... | PACLITAXEL PACLITAXEL | Gland Pharma Limited | 2016-09-30 |
| 68083-0179-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (68083-179-01) / 16.7 mL in... | PACLITAXEL PACLITAXEL | Gland Pharma Limited | 2016-09-30 |
| 68083-0180-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (68083-180-01) / 50 mL in 1... | PACLITAXEL PACLITAXEL | Gland Pharma Limited | 2016-09-30 |
| 69339-0227-05 | 1 VIAL, MULTI-DOSE in 1 CARTON (69339-227-05) / 5 mL in 1 V... | Paclitaxel | Natco Pharma USA LLC | 2024-11-07 |
| 69339-0228-17 | 1 VIAL, MULTI-DOSE in 1 CARTON (69339-228-17) / 16.7 mL in... | Paclitaxel | Natco Pharma USA LLC | 2024-11-07 |
| 69339-0229-50 | 1 VIAL, MULTI-DOSE in 1 CARTON (69339-229-50) / 50 mL in 1... | Paclitaxel | Natco Pharma USA LLC | 2024-11-07 |
| 72162-2640-02 | 1 VIAL, MULTI-DOSE in 1 CARTON (72162-2640-2) / 50 mL in 1... | Paclitaxel | Bryant Ranch Prepack | 2026-05-06 |
| 72205-0061-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (72205-061-01) / 5 mL in 1 V... | Paclitaxel | Novadoz Pharmaceuticals LLC | 2020-08-26 |
| 72205-0062-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (72205-062-01) / 16.7 mL in... | Paclitaxel | Novadoz Pharmaceuticals LLC | 2020-08-26 |
| 72205-0063-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (72205-063-01) / 50 mL in 1... | Paclitaxel | Novadoz Pharmaceuticals LLC | 2020-08-26 |
Observed labelers:
Teva Parenteral Medicines, Inc. (7) ·
Hospira, Inc. (4) ·
Alembic Pharmaceuticals Inc. (3) ·
Alembic Pharmaceuticals Limited (3) ·
Gland Pharma Limited (3) ·
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (3)
· +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9267 | Paclitaxel injection | 25 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.